ABU DHABI receives first shipment of new AstraZeneca “Evusheld”

Abu Dhabi received the first shipment of AstraZeneca’s Evusheld, after gaining Emergency Use Authorization (EUA) from the UAE’s Ministry of Health and Prevention. The medication is designed to prevent infection and death amongst immunocompromised patients. This medication will be in addition to the existing COVID-19 medications that are already available within Abu Dhabi and the UAE to ensure the continuity of world-class care in the country. Under the leadership of the Department of Health, the first doses of Evusheld have arrived in Abu Dhabi on December 20, 2021 following a tie-up of partners such as Rafed, the UAE’S Primary Group Purchasing Organization and the nation’s procurement arm along with Etihad Cargo, AstraZeneca, the British-Swedish MNC, and Abu Dhabi Airports Company (ADAC).